Aleksandra Maria Zabost

Dr. Aleksandra Maria Zabost


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2024 in Applied Sciences
Verified
Journal Article
Open access
PDF file
AZAleksandra Maria Zabost
Aleksandra Maria Zabost
ECElżbieta Czarnowska
Elżbieta Czarnowska
EJEwa A. Jankowska-Steifer
Ewa A. Jankowska-Steifer
JNJustyna Niderla-Bielińska
Justyna Niderla-Bielińska
TZTymoteusz Zera
Tymoteusz Zera
ARAnna Ratajska
Anna Ratajska
Cardiac lymphatic vessels (LyVs) are suggested to be important players in cardiovascular disease-associated myocardial remodeling. However, there is a gap in the knowledge of whether LyV remodeling is an integral component of cardiac remodeling, especially in obesity associated with other comorbidities, including increased levels of circulating angiotensin II (Ang II). We studied the structural alterations in the myocardium and LyVs in Ang II-treated db/db mice compared with db/db mice and Ang II-treated wild-type mice with histopathological imaging methods, confocal microscopy, ultrastructural morphology, and morphometric analysis. We demonstrated that Ang II-treated db/db mice exhibited significantly increased fibrosis, cardiomyocyte hypertrophy, and local edema compared with untreated db/db mice; however, the cardiomyocyte hypertrophy was similar to that in Ang II-treated control mice. The decreased density of the LyVs and their wall shape alterations, with disorganized anchoring filaments, widened junctional gaps, decreased numbers of cytoplasmic vesicles indicative of a leaky phenotype, and increased basement membrane (BM) thickness, were observed in Ang II-treated db/db mice compared with Ang II-treated controls. Our findings revealed a structural basis for intensive LyV remodeling in association with cardiac remodeling in obesity.

9 January 2026 in Pathophysiology
Verified
Journal Article
Open access
PDF file
EJEwa A. Jankowska-Steifer
Ewa A. Jankowska-Steifer
ARAnna Ratajska
Anna Ratajska
AZAleksandra Maria Zabost
Aleksandra Maria Zabost
DRDorota Magdalena Radomska-Leśniewska
Dorota Magdalena Radomska-Leśniewska
IBIwona Badurek
Iwona Badurek
JNJustyna Niderla-Bielińska
Justyna Niderla-Bielińska
Background/Objectives: Metabolic syndrome (MetS) conditions lead to structural and functional alterations in cardiomyocytes, microvasculature, and extracellular matrix (ECM), leading to myocardial fibrosis and impaired diastolic function. Cardiac lymphatic vessels (LVs) are increasingly recognized as key regulators of myocardial homeostasis, yet their response to MetS remains poorly understood. Therefore, we aimed to investigate transcriptional changes in cardiac lymphatic endothelial cells (LECs) in db/db mice, a well-established model of MetS. Methods: Using flow cytometry-sorted LECs and RT-PCR, we analyzed mRNA expression of genes involved in lymphangiogenesis, metabolism, mechanotransduction, immune cell trafficking, and ECM interactions. Results: Our findings show the transcriptional plasticity of cardiac LECs in response to MetS. Conclusions: Although our study is limited by the lack of protein-level validation and functional assays, our approach provides a broader interpretative framework and identifies potential directions for future research, including functional studies and pathway-specific investigations of the identified genes to assess their impact on lymphatic flow and cardiac function. Understanding LEC responses to metabolic stress may uncover novel therapeutic targets for heart failure associated with MetS.